scholarly journals Is the 2000 CDC growth reference appropriate for developing countries?

2006 ◽  
Vol 9 (2) ◽  
pp. 266-268 ◽  
Author(s):  
Dominique Roberfroid ◽  
Marie-Paule Lerude ◽  
Armando Pérez-Cueto ◽  
Patrick Kolsteren
Keyword(s):  
World Health ◽  
Growth Charts ◽  
Health Statistics ◽  
Growth Reference ◽  
Control And Prevention ◽  
The Usa ◽  
Growth References ◽  
Continued Use ◽  
Using Data ◽  
Health Organization

AbstractIn 2000, the Centers for Disease Control and Prevention (CDC) produced a revised growth reference. This has already been used in different settings outside the USA. Using data obtained during a nutritional survey in Madagascar, we compare results produced by using both the 2000 CDC and the 1978 National Center for Health Statistics (NCHS)/World Health Organization (WHO) growth references. We show that changing the reference has an important impact on nutritional diagnosis. In particular, the prevalence of wasting is greatly increased. This could generate substantial operational and clinical difficulties. We recommend continued use of the 1978 NCHS/WHO reference until release of the new WHO multi-country growth charts.

scholarly journals The effects of COVID-19 pandemic on the provision of urgent surgery: a perspective from the USA

2020 ◽  
Vol 2020 (4) ◽  
Author(s):  
Abhiman Cheeyandira
Keyword(s):  
Disease Control ◽  
Surgical Care ◽  
Lessons Learned ◽  
World Health ◽  
Urgent Surgery ◽  
The World ◽  
Control And Prevention ◽  
The Usa ◽  
Health Organization ◽  
Made In

Abstract Corona virus pandemic has affected all the 50 states in the USA. States such as NY, CA and WA being the most affected. According to the Centers for Disease Control and Prevention (CDC) website, as of 28 March 2020, the total number of cases in the USA is over 103 300 and number of deaths to 1668. In the coming weeks, COVID-19 rates are expected to begin skyrocketing and hit a peak in late April/May/June given lessons learned from China, Italy and others. COVID-19 has been declared a pandemic by the World Health Organization (WHO) as confirmed cases approach 575 444 patients with 26 654 deaths across over 160 countries, as of 28 March 2020. There is a lot of impact on management of the urgent and emergent cases. This article highlights the changes that are being made in delivering urgent and emergent surgical care during the pandemic.

scholarly journals Prevalence of Stunting According to WHO Growth Standards and Indonesian Growth Reference Charts: A Descriptive Study from Blega Sub-District

2021 ◽  
Vol 7 (2) ◽  
pp. 98
Author(s):  
Nafiys Hilmy ◽  
Maitsa' Fatharani
Keyword(s):  
World Health Organization ◽  
Secondary Data ◽  
Child Growth ◽  
World Health ◽  
P Value ◽  
Growth Charts ◽  
Growth Standards ◽  
Growth Reference ◽  
Health Organization ◽  
National Growth

Stunting is one of the remaining health issues in Indonesia and its prevalence was still high in the last decades. There are two types of growth charts that can be used in recording the child's growth: growth standards and growth references. In recent times, the selection of the suitable growth charts has become a subject of discussion in many countries. The objective of this study is to describe the prevalence of stunting according to World Health Organization Child Growth Standards (WHOCGS) and Indonesian National Growth Reference Charts (INGRC) of children under five from the Blega sub-district. The secondary data from 2884 children were collected recapitulation of the 'Bulan Timbang' program in February 2020. Z-score of length/height-for-age was plotted according to WHOCGS and INGRC. The result showed that the prevalence of stunting were lower for the INGRC than WHOCGS (5.83% and 11.17%, with p-value <0.001). There was an advantage and disadvantage when using both two growth charts. Further research is still needed to support the result of this study. Keywords:  Stunting, World Health Organization Child Growth Standards, Indonesian National Growth Reference Charts

Use of World Health Organization and CDC Growth Charts for Children Aged 0–59 Months in the United States (Excerpt)

2011 ◽  
Vol 2 (2) ◽  
pp. 11-13 ◽  
Keyword(s):  
United States ◽  
Expert Panel ◽  
Scientific Evidence ◽  
The United States ◽  
World Health ◽  
Growth Charts ◽  
Clinical Settings ◽  
International Growth ◽  
Control And Prevention ◽  
Health Organization

In 2006, the Centers for Disease Control and Prevention (CDC), the National Institutes of Health, and the American Academy of Pediatrics convened an expert panel to review scientific evidence and discuss the potential use of the new WHO growth charts in clinical settings in the United States. On the basis of input from this expert panel, CDC recommends that clinicians in the United States use the 2006 WHO international growth charts, rather than the CDC growth charts, for children aged <24 months (available at https://www.cdc.gov/growthcharts). The CDC growth charts should continue to be used for the assessment of growth in persons aged 2–19 years.

scholarly journals WHO 2006 child growth standards: implications for the prevalence of stunting and underweight-for-age in a birth cohort of Gabonese children in comparison to the Centers for Disease Control and Prevention 2000 growth charts and the National Center for Health Statistics 1978 growth references

2008 ◽  
Vol 11 (7) ◽  
pp. 714-719 ◽  
Author(s):  
Norbert G Schwarz ◽  
Martin P Grobusch ◽  
Marie-Luise Decker ◽  
Julia Goesch ◽  
Marc Poetschke ◽  
...  
Keyword(s):  
Disease Control ◽  
Birth Cohort ◽  
Child Growth ◽  
Growth Charts ◽  
Health Statistics ◽  
Growth Standards ◽  
Growth Faltering ◽  
Control And Prevention ◽  
Growth References ◽  
Centers For Disease Control

AbstractObjectivesTo assess the proportion of children being stunted and underweight-for-age at 3, 9 and 15 months in Lambaréné, Gabon, using the WHO child growth standards released in 2006 as compared with the Centers for Disease Control and Prevention (CDC) 2000 and the National Center for Health Statistics (NCHS) 1978 child growth charts/references.Design and settingProspective birth cohort in Lambaréné, Gabon.SubjectsTwo hundred and eighty-nine children from birth to 15 months of age.MethodsWeight and length were recorded at 3, 9 and 15 months. CorrespondingZscores for stunting and underweight-for-age were calculated for the three different standards/references. Children with a height-for-age or weight-for-age below –2sdof the corresponding reference median (Zscore ≤−2) were classified as stunted or underweight-for-age, respectively.ResultsWith the new WHO 2006 standards a higher proportion (4·0 %) of 3-month-old infants were underweight compared with the CDC (1·0 %) or the NCHS (0·7 %) child growth charts/references. In contrast to the NCHS references or the CDC charts, this proportion did not increase from 3 to 9 months or from 9 to 15 months. The proportion of children being stunted was highest (above 20 %) with the WHO 2006 standards at all three ages. Again, in contrast to the old standards, this proportion did not increase from 3 to 9 months or from 9 to 15 months.ConclusionsThe present results show considerably different growth faltering patterns for Gabonese children depending on the growth charts used to assess the prevalence of stunting and underweight. Shifting to the new WHO child growth standards may have important implications for child health programmes.

scholarly journals The Clinical Trial Landscape for Melanoma Therapies

2019 ◽  
Vol 8 (3) ◽  
pp. 368 ◽  
Author(s):  
Sonia Wróbel ◽  
Małgorzata Przybyło ◽  
Ewa Stępień
Keyword(s):  
Clinical Trials ◽  
Historical Context ◽  
Modern Medicine ◽  
World Health ◽  
Cancer Information ◽  
Data Repositories ◽  
Control And Prevention ◽  
The Usa ◽  
Health Organization ◽  
Clinical Trials Registry

(1) Despite many years of research, melanoma still remains a big challenge for modern medicine. The purpose of this article is to review publicly available clinical trials to find trends regarding the number of trials, their location, and interventions including the most frequently studied drugs and their combinations. (2) We surveyed clinical trials registered in the International Clinical Trials Registry Platform (ICTRP), one of the largest databases on clinical trials. The search was performed on 30 November 2018 using the term “melanoma”. Data have been supplemented with the information obtained from publicly available data repositories including PubMed, World Health Organization, National Cancer Institute, Centers for Disease Control and Prevention, European Cancer Information System, and many others to bring the historical context of this study. (3) Among the total of 2563 clinical trials included in the analysis, most have been registered in the USA (1487), which is 58% of the total. The most commonly studied drug in clinical trials was ipilimumab, described as applied intervention in 251 trials. (4) An increase in the number of melanoma clinical trials using immunomodulating monoclonal antibody therapies, small molecule-targeted therapies (inhibitors of BRAF, MEK, CDK4/6), and combination therapies is recognized. This illustrates the tendency towards precision medicine.

scholarly journals First Ukrainian Growth References for Height, Weight, and Body Mass Index for Children and Adolescents Aged 7 to 18 Years

2018 ◽  
Vol 2018 ◽  
pp. 1-10 ◽  
Author(s):  
Serhiy Nyankovskyy ◽  
Katarzyna Dereń ◽  
Justyna Wyszyńska ◽  
Olena Nyankovska ◽  
Edyta Łuszczki ◽  
...  
Keyword(s):  
Body Mass Index ◽  
Children And Adolescents ◽  
Body Mass ◽  
Pediatric Population ◽  
World Health ◽  
Growth Charts ◽  
Clinical Tool ◽  
National Implementation ◽  
Growth References ◽  
Health Organization

Introduction. To date, growth centiles of children and adolescents have not been created in Ukraine. Therefore, the aim of this study was to construct reference growth charts for height, weight, and body mass index (BMI) of Ukrainian school-aged children and to compare them with World Health Organization references from 2007 for children’s BMI. Material and Methods. Among the representative sample of 13,712 students (aged 7 to 18 years) who were included in this study, 6,582 (48%) were boys and 7,130 (52%) were girls. Assessments of height, body mass, and BMI of participants were performed. Reference charts were developed using LMS models within the ChartMaker lms program. Results. We present first growth references for height, weight, and body mass index for Ukrainian children and adolescents aged 7 to 18 years. The younger Ukrainian pediatric population (7-13 years) was heavier than population reported in the multiethnic WHO references, while the older (13-18 years) had lower body weight comparing to the same references from WHO. Conclusions. The constructed reference growth charts are a benchmark for following secular trends in Ukraine and are also an optimal clinical tool for health care. We recommend national implementation of the Ukrainian reference growth charts for anthropometric measurements.

Sign in / Sign up

Export Citation Format

Share Document